Fesomersen | Interleukin Related interleukin-related.com

Product Name :
Fesomersen

Search keywords :
Fesomersen

drugId :
null

Target Vo:
Coagulation factor XI

Target Vo Short Name :
F11

Moa_Name:
Coagulation factor XI inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :
Bayer AG

Active Indication_Name:
Nephrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DNMT1 Mouse mAb Technical Information
HtrA2 (YP6097) Mouse mAb site
AXL Antibody: AXL Antibody is an unconjugated, approximately 95 kDa, rabbit-derived, anti-AXL polyclonal antibody. AXL Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts